Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.4 USD | -0.19% | +0.80% | -5.38% |
04-17 | North American Morning Briefing : Stock Futures -2- | DJ |
04-16 | Piper Sandler Upgrades CNO Financial Group to Overweight From Neutral, Price Target is $29 | MT |
Chart calendar CNO Financial Group, Inc.
Upcoming events on CNO Financial Group, Inc.
Past events on CNO Financial Group, Inc.
Today | Q1 2024 Earnings Release After hours |
06/03/2024 | Ex-dividend day |
07/02/2024 17:00 | Q4 2023 Earnings Call |
06/02/2024 21:15 | Q4 2023 Earnings Release |
06/12/2023 | Ex-dividend day |
05/12/2023 17:20 | Goldman Sachs U.S. Financial Services Conference |
07/11/2023 16:00 | Q3 2023 Earnings Call |
06/11/2023 21:15 | Q3 2023 Earnings Release |
06/09/2023 | Ex-dividend day |
01/08/2023 16:00 | Q2 2023 Earnings Call |
31/07/2023 21:15 | Q2 2023 Earnings Release |
07/06/2023 | Ex-dividend day |
10/05/2023 13:00 | Annual General Meeting |
02/05/2023 16:00 | Q1 2023 Earnings Call |
01/05/2023 21:20 | Q1 2023 Earnings Release |
08/03/2023 | Ex-dividend day |
23/02/2023 18:30 | Investor Day |
08/02/2023 15:00 | FY 2022 Earnings Call |
07/02/2023 21:15 | FY 2022 Earnings Release |
07/12/2022 | Ex-dividend day |
Past dividends on CNO Financial Group, Inc.
06/03/2024 | Quarterly 0.15 USD |
06/12/2023 | Quarterly 0.15 USD |
06/09/2023 | Quarterly 0.15 USD |
07/06/2023 | Quarterly 0.15 USD |
08/03/2023 | Quarterly 0.14 USD |
07/12/2022 | Quarterly 0.14 USD |
07/09/2022 | Quarterly 0.14 USD |
08/06/2022 | Quarterly 0.14 USD |
08/03/2022 | Quarterly 0.13 USD |
08/12/2021 | Quarterly 0.13 USD |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 4 016 3 772 6.46% | 3 821 3 556 7.44% | 4 122 3 650 12.95% | 3 577 3 622 -1.26% | 4 147 3 648 13.67% | 3 771 |
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 357 0,00 - | 446 |
Net income Million USD | Released Forecast Spread | 409 193 112.52% | 302 275 9.59% | 441 399 10.46% | 397 418 -5.06% | 277 347 -20.34% | 339 |
EPS USD | Released Forecast Spread | 0,00 0,00 - | 2,11 1,94 8.76% | 3,36 3,05 10.34% | 3,37 3,57 -5.47% | 2,40 2,99 -19.73% | 3,09 |
Announcement Date | 11/02/20 | 09/02/21 | 08/02/22 | 07/02/23 | 06/02/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 1 075 906 18.58% | 843 916 -7.98% | 855 906 -5.62% | 905 894 1.29% | 974 910 6.98% | 1 006 926 8.64% | 1 023 916 11.65% | 948 924 2.59% | 1 171 934 25.31% | 936 | 932 | 939 | 963 | 950 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 148 94,1 57.33% | 149 86,3 73.07% | 175 70,3 149.5% | 137 72,0 90.64% | 55,4 84,9 -34.77% | -1,00 97,7 -101.02% | 96,1 102 -5.85% | 216 109 98.47% | 46,1 124 -62.68% | 92,8 | 104 | 113 | 136 | 99,1 |
Net income Million USD | Released Forecast Spread | 116 73,0 58.56% | 112 67,1 67.36% | 136 53,5 154.63% | 105 55,1 90.68% | 43,4 65,7 -33.94% | -0,80 70,1 -101.14% | 73,7 75,0 -1.67% | 167 81,5 105.4% | 36,3 95,2 -61.87% | 69,4 | 79,4 | 84,4 | 106 | 76,5 |
EPS USD | Released Forecast Spread | 0,93 0,58 59.43% | 0,93 0,55 68.07% | 1,16 0,45 157.78% | 0,91 0,48 90.91% | 0,37 0,57 -35.09% | -0,01 0,61 -101.64% | 0,64 0,65 -1.54% | 1,46 0,72 103.48% | 0,32 0,85 -62.35% | 0,62 | 0,72 | 0,77 | 0,98 | 0,72 |
Announcement Date | 08/02/22 | 02/05/22 | 01/08/22 | 31/10/22 | 07/02/23 | 01/05/23 | 31/07/23 | 06/11/23 | 06/02/24 | - | - | - | - | - |
29/04/2024 | HUBEI BIOCAUSE PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release |
29/04/2024 | HUBEI BIOCAUSE PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release |
29/04/2024 | STAR HEALTH AND ALLIED INSURANCE COMPANY LIMITED: Q4 2024 Earnings Release |
30/04/2024 21:15 | UNUM GROUP: Q1 2024 Earnings Release |
30/04/2024 21:15 | PRUDENTIAL FINANCIAL, INC.: Q1 2024 Earnings Release |
30/04/2024 | METLIFE, INC.: Q1 2024 Earnings Release |
30/04/2024 | AFLAC INCORPORATED: Q1 2024 Earnings Release |
30/04/2024 | GREAT-WEST LIFECO INC.: Q1 2024 Earnings Release |
01/05/2024 | HANWHA CORPORATION: Q1 2024 Earnings Release |
02/05/2024 12:00 | LINCOLN NATIONAL CORPORATION: Q1 2024 Earnings Release |
Past sector events for CNO Financial Group, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CNO Stock
- Calendar CNO Financial Group, Inc.